Roberta Rudà

25PUBLICATIONS

179CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesLiquid biopsiesSolid tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (25)

Sort by Publication Date:

|Jun 16, 2026

Long-Term Outcome of Molecularly Defined Oligodendrogliomas: Comparison of Grade 2 and 3 Tumors.

|Sep 16, 2025

Early seizure freedom with [<sup>18</sup>F]fluorodopa positron emission tomography response after isocitrate dehydrogenase inhibition with vorasidenib: First case report.

Roberta Rudà, Francesco Bruno, Alessia Pellerino

|Sep 02, 2025

Glutamate to GABA ratio is elevated in patients with IDH-mutant lower-grade gliomas and seizures.

Riccardo Pascuzzo, Roberta Rudà, Peter B Barker

|Aug 30, 2025

Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium.

Chetan Bettegowda, Houtan Noushmehr, Alessandra Affinito

|Aug 12, 2025

STAT3 expression in brain metastases from breast cancer is correlated with molecular subtype and impacts clinical outcome.

Alessia Pellerino, Neibla Priego, Luca Bertero

|Aug 05, 2025

The concept, intention, and evaluation of the term treatment-refractory meningioma.

Lasse Rehné Jensen, Andrea Daniela Maier, Tareq A Juratli

Pageof 5

Frequent Collaborators

11 joint publications

Riccardo Soffietti

Alessia Pellerino

Francesco Bruno

Luca Bertero

Matthias Preusser

Antonio Silvani

Michael Weller

Edoardo Pronello

Marco Rossi

Paola Cassoni

Frequent Collaborators

11 joint publications

Riccardo Soffietti

8 joint publications

Alessia Pellerino

6 joint publications

Francesco Bruno

5 joint publications

Luca Bertero